Cost and cost effectiveness of reactive case detection (RACD), reactive focal mass drug administration (rfMDA) and reactive focal vector control (RAVC) to reduce malaria in the low endemic setting of Namibia: an analysis alongside a 2×2 factorial design cluster randomised controlled trial

Henry Ntuku, Cara Smith-Gueye, Valerie Scott, Joseph Njau, Brooke Whittemore, Brittany Zelman, Munyaradzi Tambo, Lisa M. Prach, Lindsey Wu, Leah Schrubbe, Mi Suk Kang Dufour, Agnes Mwilima, Petrina Uusiku, Hugh Sturrock, Adam Bennett, Jennifer Smith, Immo Kleinschmidt, Davis Mumbengegwi, Roly Gosling, Michelle Hsiang

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Cost and cost effectiveness of reactive case detection (RACD), reactive focal mass drug administration (rfMDA) and reactive focal vector control (RAVC) to reduce malaria in the low endemic setting of Namibia: an analysis alongside a 2×2 factorial design cluster randomised controlled trial'. Together they form a unique fingerprint.

Cost and cost effectiveness of reactive case detection (RACD), reactive focal mass drug administration (rfMDA) and reactive focal vector control (RAVC) to reduce malaria in the low endemic setting of Namibia: an analysis alongside a 2×2 factorial design cluster randomised controlled trial

Fingerprint

Medicine & Life Sciences